CS199274B2 - Process for the asymetric concersion of 2-deutero-3-fluor-l-alanine into corresponding d-isomer - Google Patents
Process for the asymetric concersion of 2-deutero-3-fluor-l-alanine into corresponding d-isomer Download PDFInfo
- Publication number
- CS199274B2 CS199274B2 CS761182A CS118276A CS199274B2 CS 199274 B2 CS199274 B2 CS 199274B2 CS 761182 A CS761182 A CS 761182A CS 118276 A CS118276 A CS 118276A CS 199274 B2 CS199274 B2 CS 199274B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- deutero
- alanine
- fluoro
- isomer
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C265/00—Derivatives of isocyanic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/19—Acids containing three or more carbon atoms
- C07C53/21—Acids containing three or more carbon atoms containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
- C07C59/19—Pyruvic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Vynález se obecně týká způsobu přípravy 2-deutero-3-fluor-D-alaninu a jeho farmaceuticky vhodné soli, které jsou účinnými antibakteriálními činidly, použitelnými při inhibici růstu patogenních bakterií, jak grampositivního, tak gramnegativního typu. Přesněji se vynález týká nového asymetrického postupu, při kterém se 2-deutero-3-fluor-L-alanin převádí na jeho D-isomer.The invention generally relates to a process for the preparation of 2-deutero-3-fluoro-D-alanine and pharmaceutically acceptable salts thereof which are potent antibacterial agents useful in inhibiting the growth of pathogenic bacteria of both the Gram-positive and Gram-negative type. More specifically, the invention relates to a novel asymmetric process in which 2-deutero-3-fluoro-L-alanine is converted to its D-isomer.
2-Deutero-3-fluor-L-alanin se rozpustí v silné (6N) kyselině bromovodíkové nebo kyselině chlorovodíkové, k roztoku se po částech přidá dusitan sodný a vzniklý roztok se udržuje při teplotě asi 0°C po dobu asi tří hodin a získá se tak L-2-brom-2-deutero-3-fluorpropionová kyselina nebo L-2-chlor-2-deutero-3-fluorpropíonová kyselina. 2-Halogen-2-deutero-3-fluorpropionová kyselina se běžně izoluje z kyselého reakčního roztoku extrakcí vodou nemísitelným organickým rozpouštědlem, jako je methylenchlorid, a odpařením extraktu ve vakuu. Jako odparek získaná L-2-halogen-2-deutero-3-fluorpropionová kyselina se čistí vakuovou frakční destilací. ‘2-Deutero-3-fluoro-L-alanine is dissolved in strong (6N) hydrobromic acid or hydrochloric acid, sodium nitrite is added in portions, and the resulting solution is maintained at about 0 ° C for about three hours to give thus, L-2-bromo-2-deutero-3-fluoropropionic acid or L-2-chloro-2-deutero-3-fluoropropionic acid. 2-Halogen-2-deutero-3-fluoropropionic acid is conveniently isolated from the acidic reaction solution by extraction with a water immiscible organic solvent such as methylene chloride and evaporation of the extract in vacuo. The L-2-halo-2-deutero-3-fluoropropionic acid obtained as a residue is purified by vacuum fractional distillation. ‘
Ld-broin-dmeuteiO^-fluorpropionová kyselina nebo odpovídající 2-chlor-analog se pak nechá reagovat s azidem sodným.The ld-broin-dimethoxy-4-fluoropropionic acid or the corresponding 2-chloro analog is then reacted with sodium azide.
Reakce L-2-chlor- nebo L-2-brommeziproduktu s azidem sodným se s výhodou provádí tak, že se reakční komponenty uvedou ve styk v dimethylformamidu a reakční směs se míchá při teplotě místnosti. Za těchto podmínek je reakce dokončena po jednom dni. Takto vzniklá D-2-azido-2-deutero-3-fluorpropionová kyselina se pak katalyticky hydrogenuje, přičemž se 2-azidoskupina redukuje na 2-aminoskupinu a získá se 2deutero-3-fluor-D-alanin· Postup umožňuje ' přímé převedení L-isomeru 2-deutero-3-fluoranilinu na D-isomer.The reaction of the L-2-chloro- or L-2-bromo intermediate with sodium azide is preferably carried out by contacting the reaction components in dimethylformamide and stirring the reaction mixture at room temperature. Under these conditions, the reaction is complete after one day. The D-2-azido-2-deutero-3-fluoropropionic acid thus formed is then catalytically hydrogenated, whereby the 2-azido group is reduced to the 2-amino group to give 2-deutero-3-fluoro-D-alanine. the isomer of 2-deutero-3-fluoroaniline to the D-isomer.
Jak již bylo uvedeno, 2-deutero-3-fluor-D-alanin je účinným a užitečným antibakteriálním činidlem,, zatímco isomerní 2-deutero-3-fluor-L-alanin (i když vykazuje antibakteriální účinek) je obecně nežádoucím isomerem. Tak místo racemisace Ldsomeru získaného resolucí 2-deutero-3-fluor-DL-alaninu a následující resolucí takto vznikne DL směsi se mohou .L-isomery 2-deutero-3-fluor-L-alaninu asymetricky přímo převést na 2-deutero-3-fluor-D-alanin.As mentioned above, 2-deutero-3-fluoro-D-alanine is an effective and useful antibacterial agent, while the isomeric 2-deutero-3-fluoro-L-alanine (although exhibiting an antibacterial effect) is generally an undesirable isomer. Thus, instead of the racemization of the Ldsomer obtained by resolution of 2-deutero-3-fluoro-DL-alanine and subsequent resolution to form DL mixtures, the L-isomers of 2-deutero-3-fluoro-L-alanine can be asymmetrically converted directly to 2-deutero-3. -fluoro-D-alanine.
Následující příklady objasňují způsob podle vynálezu, rozumí se však, ' že tyto příklady jsou uvedeny pouze pro objasnění a vynález jimi není žádným způsobem omezen.The following examples illustrate the process of the invention, but it is to be understood that these examples are given for the purpose of illustration only and are not intended to limit the invention in any way.
Příklad 1Example 1
2-Deutero-3-fluor-L-alanin (21,4 g] se rozpustí v 250 ml 6N vodné kyseliny bromovodíkové. Roztok se ochladí na 0 °C a po malých částech se přidá dusitan sodný (22 g), přičemž se teplota udržuje na 0 až 5 °C. Po skončení přidávání se reakční směs udržuje tři hodiny na 0°C. Roztok se extrahuje methylenchloridem a pak vysuší síranem hořečnatým. Methylenchlorid se odpaří ve vakuu. Zbylá L-2-brom-2-deutero-3-fluorpropionová kyselina se pak čistí trakční destilací ve vakuu.2-Deutero-3-fluoro-L-alanine (21.4 g) was dissolved in 250 mL of 6N aqueous hydrobromic acid, cooled to 0 ° C and sodium nitrite (22 g) was added in small portions at room temperature. The reaction mixture was maintained at 0-5 [deg.] C. After the addition was complete, the reaction mixture was maintained at 0 [deg.] C. for three hours, the solution was extracted with methylene chloride and then dried over MgSO4, and the methylene chloride was evaporated in vacuo to leave L-2-bromo-2-deutero-3. The fluoropropionic acid is then purified by traction distillation in vacuo.
L-2-brom-2-deutero-3-fluorpropionová kyselina (3,0 g) se rozpustí v 20 ml dimethylformamidu, přidá se azid sodný (1,0 g) a směs se míchá 24 hodin při 25 °C. Směs se naleje do vody a extrahuje etherem. Etherický extrakt se promyje vodou a vysuší. К filtrátu se přidá asi 20 ml ethanolu a vzniklý roztok D-2-azido-2-deutero-3-fluorpropionové kyseliny se nechá reagovat s vodíkem v přítomnosti 0,5 g 5% palladia na uhlí. Katalyzátor se odfiltruje a rozpouštědlo se odpaří ve vakuu. Získá se surový 2-deutero-3L-2-bromo-2-deutero-3-fluoropropionic acid (3.0 g) was dissolved in 20 ml of dimethylformamide, sodium azide (1.0 g) was added, and the mixture was stirred at 25 ° C for 24 hours. The mixture was poured into water and extracted with ether. The ether extract was washed with water and dried. About 20 ml of ethanol are added to the filtrate and the resulting D-2-azido-2-deutero-3-fluoropropionic acid solution is treated with hydrogen in the presence of 0.5 g of 5% palladium on carbon. The catalyst was filtered off and the solvent was evaporated in vacuo. Crude 2-deutero-3 is obtained
-fluor-D-alanin, který se čistí krystalisací z vodného isopropanolu.-fluoro-D-alanine, which is purified by crystallization from aqueous isopropanol.
Příklad 2Example 2
2-Deutero-3-fluor-L-alanin (21,4 g) se rozpustí v 250 ml 6N vodné kyseliny chlorovodíkové. Roztok se ochladí na 0°C a po malých dávkách se přidává dusitan sodný (22 gramů] tak, že se teplota udržuje na 0—5 °C. Po skončení přidávání se reakční roztok udržuje tři hodiny na 0 °C. Vzniklý roztok se extrahuje methylenchloridem, extrakt se vysuší síranem hořečnatým a methylenchlorid se odpaří ve vakuu. Jako odparek získaný L-2-chlor-2-deutero-3-fluorpropionová kyselina se čistí ve vakuu frakční destilací.2-Deutero-3-fluoro-L-alanine (21.4 g) was dissolved in 250 mL of 6N aqueous hydrochloric acid. The solution was cooled to 0 ° C and sodium nitrite (22 grams) was added in small portions while maintaining the temperature at 0-5 ° C. After the addition was complete, the reaction solution was kept at 0 ° C for three hours. The methylene chloride was evaporated in vacuo, and the L-2-chloro-2-deutero-3-fluoropropionic acid obtained as a residue was purified by vacuum fractional distillation.
L-2-chlor-2-deutero-3-fluorpropionová kyselina (2,0^ g) se rozpustí v 20 ml dimethylformamidu. Přidá se azid sodný (1,0 g) a směs se míchá 24 hodin při 25 °C. Směs se naleje do vody a D-2-azido-2-deutero-3-fluorpropionová kyselina se katalyticky hydrogenuje a produkt se čistí krystalisací ze směsi 50% vodného isopropanolu. Získá se tak 2-deutero-3-fluar-D-alanin.L-2-chloro-2-deutero-3-fluoropropionic acid (2.0 µg) was dissolved in 20 ml of dimethylformamide. Sodium azide (1.0 g) was added and the mixture was stirred at 25 ° C for 24 h. The mixture was poured into water and D-2-azido-2-deutero-3-fluoropropionic acid was catalytically hydrogenated and the product was purified by crystallization from 50% aqueous isopropanol. There was thus obtained 2-deutero-3-fluoro-D-alanine.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/552,474 US3950411A (en) | 1972-02-03 | 1975-02-24 | Processes for asymmetric conversion of 3-fluoro-L-alanine and 2-deutero-3-fluoro-L-alanine to their D-isomers |
Publications (1)
Publication Number | Publication Date |
---|---|
CS199274B2 true CS199274B2 (en) | 1980-07-31 |
Family
ID=24205490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS761182A CS199274B2 (en) | 1975-02-24 | 1976-02-23 | Process for the asymetric concersion of 2-deutero-3-fluor-l-alanine into corresponding d-isomer |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS51110513A (en) |
AR (1) | AR207277A1 (en) |
AU (1) | AU500536B2 (en) |
CA (1) | CA1045157A (en) |
CH (1) | CH620194A5 (en) |
CS (1) | CS199274B2 (en) |
DE (1) | DE2607252A1 (en) |
DK (1) | DK55976A (en) |
ES (1) | ES445381A1 (en) |
FI (1) | FI760302A7 (en) |
FR (1) | FR2301513A1 (en) |
GB (1) | GB1488332A (en) |
GR (1) | GR59306B (en) |
HU (1) | HU173362B (en) |
IE (1) | IE43351B1 (en) |
NL (1) | NL7601511A (en) |
NO (1) | NO760448L (en) |
PT (1) | PT64805B (en) |
SE (1) | SE7601423L (en) |
YU (1) | YU41876A (en) |
ZA (1) | ZA761045B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3880922A (en) * | 1972-02-03 | 1975-04-29 | Merck & Co Inc | Process for preparing 3-fluoro-D-alanine by asymmetric rearrangement of 2-(azidocarbonyl)-3-fluoro-propionic ester or nitrile |
-
1976
- 1976-01-01 AR AR262279A patent/AR207277A1/en active
- 1976-02-09 FI FI760302A patent/FI760302A7/fi not_active Application Discontinuation
- 1976-02-10 SE SE7601423A patent/SE7601423L/en unknown
- 1976-02-11 DK DK55976*#A patent/DK55976A/en unknown
- 1976-02-12 NO NO760448A patent/NO760448L/no unknown
- 1976-02-13 NL NL7601511A patent/NL7601511A/en not_active Application Discontinuation
- 1976-02-16 PT PT64805A patent/PT64805B/en unknown
- 1976-02-17 CH CH193076A patent/CH620194A5/en not_active IP Right Cessation
- 1976-02-17 AU AU11178/76A patent/AU500536B2/en not_active Expired
- 1976-02-17 GR GR50072A patent/GR59306B/en unknown
- 1976-02-18 CA CA246,060A patent/CA1045157A/en not_active Expired
- 1976-02-19 YU YU00418/76A patent/YU41876A/en unknown
- 1976-02-19 GB GB6655/76A patent/GB1488332A/en not_active Expired
- 1976-02-20 FR FR7604715A patent/FR2301513A1/en active Granted
- 1976-02-20 IE IE335/76A patent/IE43351B1/en unknown
- 1976-02-20 ES ES445381A patent/ES445381A1/en not_active Expired
- 1976-02-23 DE DE19762607252 patent/DE2607252A1/en not_active Withdrawn
- 1976-02-23 ZA ZA761045A patent/ZA761045B/en unknown
- 1976-02-23 CS CS761182A patent/CS199274B2/en unknown
- 1976-02-24 JP JP51018580A patent/JPS51110513A/ja active Pending
- 1976-02-24 HU HU76ME1954A patent/HU173362B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES445381A1 (en) | 1977-06-01 |
AU1117876A (en) | 1977-08-25 |
CH620194A5 (en) | 1980-11-14 |
FI760302A7 (en) | 1976-08-25 |
SE7601423L (en) | 1976-08-25 |
DK55976A (en) | 1976-08-25 |
PT64805B (en) | 1978-02-06 |
AR207277A1 (en) | 1976-09-22 |
CA1045157A (en) | 1978-12-26 |
DE2607252A1 (en) | 1976-09-02 |
IE43351B1 (en) | 1981-02-11 |
YU41876A (en) | 1982-02-28 |
GB1488332A (en) | 1977-10-12 |
FR2301513A1 (en) | 1976-09-17 |
GR59306B (en) | 1977-12-12 |
ZA761045B (en) | 1977-09-28 |
JPS51110513A (en) | 1976-09-30 |
PT64805A (en) | 1976-03-01 |
NO760448L (en) | 1976-08-25 |
FR2301513B1 (en) | 1979-02-02 |
NL7601511A (en) | 1976-08-26 |
HU173362B (en) | 1979-04-28 |
IE43351L (en) | 1976-08-21 |
AU500536B2 (en) | 1979-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT405283B (en) | NEW CRYSTALLINE 7- (Z) - (2- (2-AMINOTHIAZOL-4-YL) -2-HYDROXYIMINOACETAMIDO) -3-VINYL-3-CEPHEM-4- CARBONIC ACID DICYCLOHEXYLAMMONIUM SALTS AND METHODS FOR THE PRODUCTION THEREOF | |
CS220790B2 (en) | Method of separation of the -6-methoxy-alpha-methyl-2-naphtalene vinegar acid from the mixtures of the a/-/-6-methoxy-alpha-methyl-2/naphtalene vinegar acid or salts thereof | |
FR2476088A2 (en) | NOVEL NOR-TROPANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
EP0496238A1 (en) | Substituted benzoxazepines and benzothiazepines, process for their preparation and their use as medicaments | |
JPH0246565B2 (en) | ||
CH661507A5 (en) | DERIVATIVES OF HYDROXYMETHYL-5 OXAZOLIDINONE-2 N-ARYLATED AND THEIR PREPARATION PROCESS. | |
US3962223A (en) | Substituted cephene-4-carboxylates and their method of preparation | |
CS199274B2 (en) | Process for the asymetric concersion of 2-deutero-3-fluor-l-alanine into corresponding d-isomer | |
EP0252353B1 (en) | 4-benzyloxy-3-pyrrolin-2-one-1-yl-acetamide, preparation and use | |
FI61880B (en) | EXAMINATION OF N-ARYL SULPHONYL-N '- (3-AZABICYCLOALKYL) -URINAEMNEN | |
US6576764B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
EP0962552B1 (en) | A process for the preparation of 4-(des-dimethylamino)-tetracyclines | |
AU681703B2 (en) | Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid | |
GB2025395A (en) | Therapeutically active substituted dibenzyl ethers | |
EP0003455B1 (en) | 3-amino-cardenolides, process for their preparation and medicines containing them | |
EP0138708B1 (en) | Isoefrotomycin | |
US3870744A (en) | Process for oxygen-alkylation of sterically hindered phenols | |
McKay et al. | Reaction of Amino Alcohols with Carbon Disulphide | |
US2832783A (en) | Preparation of piperazine adipate | |
US4073807A (en) | Propionamide antitumor agents | |
US6307103B1 (en) | Process for the preparation of 1,1,1-trifluoro-2-aminoalkanes | |
Jackson | Certain N-Alkyl, N-Carboxyalkyl and N-Hydroxyalkyl Derivatives of 4, 4'-Diamino-diphenyl Sulfone | |
US4169834A (en) | Rifamycin derivatives | |
FI61700B (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV 2-AMINO-BENZYLAMINER | |
BG64021B1 (en) | Sodium salt of 3-(4-cinnamyl-1-piperazinyl)-iminomethyl rifamycin and method for its preparation |